Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment
Approximately 40% of lung cancer patients will develop central nervous system (CNS) metastases during the course of their disease. Most of these are brain metastases, but up to 10% will develop leptomeningeal metastases. Known risk factors for CNS metastases development are small cell lung cancer (S...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Online |
| Idioma: | anglès |
| Publicat: |
Frontiers Media SA
2021
|
| Matèries: | |
| Accés en línia: | 32076 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Ítems similars: Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment
- Mechanisms and Therapy for Cancer Metastasis to the Central Nervous System
- Metastasis
- Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
- Integrating Clinical and Translational Research Networks—Building Team Medicine - Series 2
- The Role of Modern Neuro-oncology in the Treatment of Primary CNS Tumors, and Brain and Spinal Metastases
- Clinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate